Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer
ImmunoHorizons · 2026
DOI: 10.1093/immhor/vlaf084 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, 2026. Verfasst von Marta Winkler und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States. Hauptthemen laut MEDLINE: Ovarian Neoplasms, T-Lymphocytes. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Aberrant angiogenesis in ovarian cancer (OC), driven by excessive vascular endothelial growth factor (VEGF) and other proangiogenic mediators, gives rise to structurally and functionally abnormal tumor vasculature that hinders effective T-cell infiltration. To overcome these barriers, we investigated how modulation of the perivascular niche influences antitumor T-cell trafficking and function in OC. T cells expressing a rearranged TCR transgene specific for SV40 T antigen (TAG) were adoptively transferred into TAG+ MOVCAR 5009 ovarian tumor–bearing SCID mice or syngeneic TgMISIIR-TAg-Low transgenic mice, which express TAG as a self-antigen in the fallopian tube epithelium. Transfers were performed either alone or following treatment with an oncolytic vaccinia virus expressing a CXCR4 antagonist (OV-CXCR4-A) or a control virus (OV-Fc). Compared with OV-Fc, OV-CXCR4-A treatment remodeled the tumor vasculature, inhibited recruitment of VEGF-producing myeloid-derived suppressor cells, and disrupted the proangiogenic microenvironment. These changes enhanced infiltration of adoptively transferred TCRTAG T cells within the perivascular niche, correlating with improved antitumor activity and survival. Collectively, our findings demonstrate that CXCR4 blockade–mediated reprogramming of the perivascular tumor microenvironment promotes effective T-cell trafficking and function, providing a mechanistic rationale for combining oncolytic virotherapy with adoptive cell transfer in OC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
- Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
- Department of Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
- Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
- Department of Obstetrics and Gynecology, University of Chicago Comprehensive Cancer Center, Chicago, IL, United States.
ORCID-Profile: Song Liu
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Winkler, M., Malhotra, N., Mistarz, A., Wang, S., Hutson, A., Gambotto, A., Abrams, S. I., Singh, P. K., Liu, S., Odunsi, K. O., Wang, J., & Kozbor, D. (2026). Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer. ImmunoHorizons. https://doi.org/10.1093/immhor/vlaf084
Vancouver
Winkler M, Malhotra N, Mistarz A, Wang S, Hutson A, Gambotto A, et al. Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer. ImmunoHorizons. 2026. doi:10.1093/immhor/vlaf084
BibTeX
@article{Winkler2026,
author = {Winkler, Marta and Malhotra, Nemi and Mistarz, Anna and Wang, Sophie and Hutson, Alan and Gambotto, Andrea and Abrams, Scott I and Singh, Prashant K and Liu, Song and Odunsi, Kunle O and Wang, Jianmin and Kozbor, Danuta},
title = {Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer},
journal = {ImmunoHorizons},
year = {2026},
doi = {10.1093/immhor/vlaf084}
}
EUVIMED